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Abstract
Background: Obesity and physical inactivity are major global public health concerns, both of which increase the
risk of insulin resistance and type 2 diabetes. Regulation of glucose homeostasis involves cross-talk between the
central nervous system, peripheral tissues, and gut microbiota, and is affected by genetics. Systemic cross-talk
between brain, gut, and peripheral tissues in glucose homeostasis: effects of exercise training (CROSSYS) aims to gain
new systems-level understanding of the central metabolism in human body, and how exercise training affects this
cross-talk.
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Methods: CROSSYS is an exercise training intervention, in which participants are monozygotic twins from pairs discordant
for body mass index (BMI) and within a pair at least the other is overweight. Twins are recruited from three population-
based longitudinal Finnish twin studies, including twins born in 1983–1987, 1975–1979, and 1945–1958. The participants
undergo 6-month-long exercise intervention period, exercising four times a week (including endurance, strength, and high-
intensity training). Before and after the exercise intervention, comprehensive measurements are performed in Turku PET
Centre, Turku, Finland. The measurements include: two positron emission tomography studies (insulin-stimulated whole-
body and tissue-specific glucose uptake and neuroinflammation), magnetic resonance imaging (brain morphology and
function, quantification of body fat masses and organ volumes), magnetic resonance spectroscopy (quantification of fat
within heart, pancreas, liver and tibialis anterior muscle), echocardiography, skeletal muscle and adipose tissue biopsies, a
neuropsychological test battery as well as biosamples from blood, urine and stool. The participants also perform a maximal
exercise capacity test and tests of muscular strength.
Discussion: This study addresses the major public health problems related to modern lifestyle, obesity, and physical
inactivity. An eminent strength of this project is the possibility to study monozygotic twin pairs that share the genome at the
sequence level but are discordant for BMI that is a risk factor for metabolic impairments such as insulin resistance. Thus, this
exercise training intervention elucidates the effects of obesity on metabolism and whether regular exercise training is able to
reverse obesity-related impairments in metabolism in the absence of the confounding effects of genetic factors.
Trial registration: ClinicalTrials.gov, NCT03730610. Prospectively registered 5 November 2018.
Keywords: Obesity, Insulin resistance, Type 2 diabetes, Exercise training, Glucose metabolism, Brain metabolism,
Monozygotic twins
Background
The increasing prevalence of obesity has become a global
public health issue. Obesity and physical inactivity are the
causes of life-style-induced diseases such as type 2 dia-
betes (T2D) [1, 2]. According to the report by World
Health Organization (WHO) in 2016, worldwide one in
11 adults has T2D, one in ten is obese, and one in three is
overweight. Importantly, most of the world’s population
live in countries where obesity is more frequent cause of
death compared with undernutrition. Hence, means to
fight this global health burden are greatly needed.
Insulin is a vital hormone that is produced in pancreatic
beta cells from where it is released into the circulation.
Among other functions insulin controls the blood glucose
level by promoting the absorption of glucose into the in-
sulin sensitive tissues such as skeletal muscle, liver and fat
tissue. Insulin also regulates the amount of glucose that is
secreted into the circulation by the liver [3].
Obesity is associated with insulin resistance and low-
grade inflammation which induce the impairment in the
metabolism and function of peripheral tissues such as
liver, skeletal muscle and pancreas [4]. Traditionally,
regulation of glucose homeostasis has been considered
as an interplay between pancreatic beta cells and periph-
eral insulin sensitive tissues. Furthermore, the dysfunc-
tion of the pancreatic beta cells together with reduced
insulin sensitivity of peripheral tissues are believed to be
the major cause of the development of insulin resistance
and T2D [5]. However, recent advances in neuroscience
have provoked an interest to study the role of brain in
more detail in obesity and the development of T2D.
Interestingly, recent studies have suggested that obesity-
induced low-grade inflammation impairs also the brain
function and disturbs glucose sensing, insulin signaling
and hypothalamic circulation in central nervous system
[6–8]. Thus, abnormal brain function induced by obesity
may play a role in the development of T2D. Therefore, a
question has emerged whether a brain-centric model of
glucose homeostasis regulation would better explain the
development of insulin resistance compared with the
traditional beta cell-centric model in obesity [5, 8].
In addition to the advances in neuroscience, the devel-
opment of multi-omics sequencing has enabled the
study of gut microbiota in greater detail. Intriguingly,
the link between the gut microbiota and the develop-
ment of obesity and insulin resistance is becoming evi-
dent [9, 10]. Thus, the current evidence indicates that
obesity and insulin resistance are systems-level condi-
tions. However, more in-depth knowledge of the
systems-level cross-talk in glucose regulation is needed
to understand the pathophysiology and development of
T2D in obesity.
The current evidence from family and twin studies
clearly indicate that genetics have an important role on
the variation of exercise capacity in the sedentary state
among healthy people. In addition to the exercise cap-
acity, the response to same exercise protocol is also
highly variable between different individuals and ex-
plained by genetic factors. In other words, some people
improve their aerobic performance to a greater extent
than the others, while some people may even worsen
their exercise capacity in response to the same exercise
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training [11, 12]. In addition to family and twin studies,
genome wide association studies (GWAS) have also sug-
gested that several single nucleotide polymorphisms may
predict the variation how people respond to aerobic ex-
ercise training [13].
According to the data acquired from family and twin
studies, obesity and metabolic diseases such as T2D, are
affected by genetic factors [14–16]. GWAS has suggested
that several quantitative trait loci are associated with the
development of T2D [17]. Thus, although regular exer-
cise training is a powerful tool to maintain glucose
homeostasis and improve insulin sensitivity, individual
variation exists in the training response [18–21].
Given that the response to exercise training is hetero-
geneous and affected by genetic factors, this study uti-
lizes a co-twin control method in order to exclude the
confounding effects of genetic factors. To pursue this
objective, we recruit monozygotic (MZ) twin pairs that
are discordant for body mass index (BMI) (difference ≥
2 kg•m− 2) and at least the other twin is overweight
(BMI ≥ 25 kg•m− 2). MZ twins share same genes at se-
quence level, are of the same sex, age and share most of
their childhood environment. Thus, they provide an
ideal research design to study the effects of regular exer-
cise training on physical performance and metabolic
health outcomes, in which the confounding effects of
genetic factors can be controlled [22]. Additionally, be-
cause twin pairs included into this study are discordant
for BMI, it is possible to examine the interaction-effect
of different baseline weight and long-term exercise while
genetic factors are controlled.
Exercise training provides an effective protection
against chronic diseases that are triggered by low-grade
systemic inflammation, such as insulin resistance [23].
As a drug-free treatment option, exercise training could
lead to significant reduction in treatment cost due to re-
duced need for medication and fewer complications due
to the improved physical fitness. We have previously
shown in the Turku PET Centre that only 2 weeks of ex-
ercise training has a positive effect not only on the me-
tabolism of the skeletal muscle [24] but also that of the
heart [25, 26], the brain [27], and the intestine [28] in
healthy, insulin resistant or type 2 diabetic participants.
We have also shown that short-time exercise training
decreases ectopic fat in the pancreas [29], liver [30], in
and around the heart [31] and increases microbial diver-
sity and decreases microbiota content related to obesity
and intestinal inflammation [32]. These short-term
intervention studies suggest that already a short exercise
training period exerts positive systems-level effects on
the metabolism of various tissues. Thus, current evi-
dence provided by our research group and others’ [33,
34] suggest that exercise is able to counteract the un-
desired disturbances in metabolism related to obesity
and T2D. However, more specified evidence of the ef-
fects of exercise training on different tissues is still
needed in overweight/obese people prone to develop
metabolic diseases such as T2D.
Systemic cross-talk between brain, gut, and peripheral
tissues in glucose homeostasis: effects of exercise training
(CROSSYS) is an exercise training intervention that
provides a unique possibility to examine the systems-
level development of insulin resistance without con-
founding effects of genetic variation. This is because
systemic regulation of glucose homeostasis is studied
in twins from MZ pairs discordant for BMI and/or
insulin resistance. We use state-of-the-art medical
imaging technology, positron emission tomography
(PET) and magnetic resonance imaging (MRI). All
participants will conduct a six-month-long progressive
exercise training intervention period that is designed
to realistically fit in demanding everyday life. The
training program is planned according to the Finnish
exercise guidelines and will include endurance, resist-
ance and, high intensity interval training.
Methods
Study design
The CROSSYS study is an exercise training intervention
with a single group assignment, and the study is pro-
spectively registered on 5th November 2018 in
ClinicalTrials.gov with the identifier NCT03730610. We
investigate the effects of exercise training on closely re-
lated physiological systems that are central for the
regulation of the body metabolism. These include: i.
tissue-specific insulin-stimulated glucose uptake (insulin
sensitivity) in brain, liver, intestine, subcutaneous and
visceral adipose tissues, in muscle and myocardium, ii.
whole-body insulin sensitivity, endogenous glucose pro-
duction and pancreas function, iii. Brain morphology
and inflammation, iv. cognitive functioning, v. ectopic
fat masses in and around organs, vi. adipocyte size,
angiogenesis, inflammation, glucose transporters, adipo-
kines and myokines in femoral muscle and abdominal
and femoral subcutaneous fat tissues, vii. Metabolomics,
viii. Comprehensive blood profile, ix. glucose tolerance
and x. microbiota diversity and the associations between
microbiota and tissue specific insulin sensitivity espe-
cially in the gut-brain axis.
The study flow is illustrated in Fig. 1. The eligibility of
the participants is first evaluated in a phone interview,
followed by a screening visit to ensure that the inclusion
criteria for the twin pair are fulfilled. During the screen-
ing visit, participants are thoroughly examined by a
medical doctor, including electrocardiography (ECG).
Within 1–4 weeks after the screening visit, the twin pairs
arrive to baseline measurements, which are described in
detail below. Then, both co-twins exercise four times a
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week for 6 months in their place of residence (Table 1),
receiving guidance from a personal trainer once a week.
At 3 months, participants take a urine and faeces sample
and fill out the food diary. After 6 months, the same
measurements as at the baseline are repeated (Fig. 1).
Participants are asked to avoid strenuous exercise as well
as caffeinated drinks and alcohol 48 h before each study
visit. The usage of nicotine-products is not restricted
prior to the measurements. Participants are required to
fast overnight (at least 10 h) before all the study days ex-
cept for the study day 1 during the visits 2 and 4 (Fig. 1).
The study is conducted at the facilities of Turku PET
Centre and Turku University Hospital (Turku, Finland)
except for the exercise tests and body composition,
which are carried out at Paavo Nurmi Centre (Turku,
Finland).
Fig. 1 Overview of the study protocol. ECG: electrocardiography; FDG: 2-deoxy-2-[18F]fluoro-D-glucose; fMRI: functional magnetic resonance imaging;
MRI: magnetic resonance imaging; MRS: magnetic resonance spectroscopy; OGTT: oral glucose tolerance test; [11C]-(R)-PK11195: 11C-labelled R isomer
of [1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide]; PET: positron emission tomography
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Participants
The participants of the CROSSYS study are monozygotic
(MZ) twin pairs that are recruited from three unique
population-based longitudinal twin studies [35–37]. Of
these three cohorts, the two younger cohorts consist of
twins from the FinnTwin12 (FT12, twins born 1983–
1987) and FinnTwin16 (FT16, twins born 1975–1979)
studies, and twins born in 1945–1957, who form part of
the older cohort from the Finnish Twin Cohort Study,
twins born in 1945–1957 (Fig. 2). The three cohorts con-
sist altogether of more than 9200 twin pairs, of which 1/3
are MZ. All twins have been identified through Finland’s
central population registry, permitting exhaustive and un-
biased ascertainment of all twins living and resident in
Finland. A total of 54 MZ pairs discordant for BMI and/or
insulin resistance have participated previously to the
TwinFat study in the University of Helsinki, and their
monozygocity has been confirmed by the genotyping of 10
informative genetic markers [38]. All these 54 pairs are in-
vited to participate in the present study. Inclusion criteria
are: MZ twins, BMI within-pair difference ≥ 2 kg•m− 2
and/or insulin resistance, and at least one of the co-twins
is overweight (BMI > 25 kg•m− 2). Exclusion criteria are:
BMI > 60 kg•m− 2, body mass > 170 kg, waist circumfer-
ence > 150 cm (due to the gantry limitations of PET and
MRI machines), mental disorder or poor compliance, eat-
ing disorder or excess use of alcohol, active ulcus disease,
diabetes requiring insulin treatment or fasting glucose >
10mmol•l-1, pregnancy, past dose of radiation, claustro-
phobia, presence of ferromagnetic objects that would
make MRI contraindicated, physical disability that would
prevent exercising, or any other condition which could
potentially endanger participant’s health during the study
or interfere with the interpretation of the results. It is
Table 1 Progressive training intervention for 26 weeks
ENDURANCE TRAINING (twice a week: one Session 1 and one Session 2)
Weeks 1–2 Weeks 3–4 Weeks 5–6 Weeks 7–9 Weeks 10–19 Weeks 20–26
Session 1 70% HRmax 30min 70% HRmax 35 min 70% HRmax 40min 70% HRmax 45 min 75% HRmax 45 min 80% HRmax 45 min
Session 2 60% HRmax 40min 60% HRmax 50 min 60% HRmax 60min 60 % HRmax 60 min 60 % HRmax 60 min 60 % HRmax 60 min
HIGH INTENSITY INTERVAL TRAINING (once a week one type of training)
Type Completion method Content of the training
Circuit Perform 4 rounds of the movements in
chronological order. Every round, spend
1min in each movement: do as many
repetitions as you can in 40 s and then
rest for 20 s. Rest 1min between the rounds
after completing all movements (1–6).
Above 80% of HRmax
1. Lunges
2. X-jump/jumping rope/mountain climber
3. Back extension




Cross training First, perform 12min of section A (switch
between two movements). Rest 1 min.
Second, perform 6min of section B. Rest
1 min.
Third, perform 6min of section C.
Above 80% of HRmax
A. 500-m row/cycling/run
10 air squats




HIIT Make each bout as hard as possible. Return
between bouts by walking calmly back to
the starting point. Repeat 4–6 times.





RESISTANCE TRAINING (once a week)
Weeks 1–9 Weeks 10–19 Weeks 20–26 Repetitions (load)
Leg press Leg press/back squat Leg press/back squat 3 × 10, (75% of 1RM)
Leg extension Bulgarian squats Hip extensions 3 × 10, (75% of 1RM)
Push-upsa Cable seated row Bent-over row 3 × 10, (75% of 1RM)
Peck-deck Bench press Bench press 3 × 10, (75% of 1RM)
Lat pulldown Lat pulldown Lat pulldown/Pull-ups 3 × 10, (75% of 1RM)
Shoulder press Shoulder press Shoulder press 3 × 10, (75% of 1RM)
Abdominal crunchesa Abdominal crunchesa Abdominal crunchesa 3 × 10
HRmax maximum heart rate
1 RM: external load that can be lifted once i.e. one repetition maximum
aBody weight exercise
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estimated that 25% of twins do not want to participate or
are not eligible to the study and another 25% will drop out
during the intervention. Hence, 30 twin pairs are expected
to successfully complete the study.
Exercise intervention
Contents of the exercise intervention
All study participants perform 26 ± 2-week training
intervention period (Table 1). The training period in-
cludes one supervised (local personal trainer) and three
unsupervised home-based exercise training sessions per
week. The mixed-type intervention period consists of
endurance, high intensity interval and resistance train-
ing. The intensity of the training is progressive, and the
individual training loads are determined with the help of
a personal trainer to meet the intensities of the protocol
(Table 1). The training intervention was planned by
three exercise physiologists (M.A.H., S.M.H, J.C.H.).
Training program includes two deload weeks in order to
avoid overtraining and injuries. These deload periods are
weeks 9 and 18. During the deload weeks, participants
perform only endurance training.
Principally, all the subjects exercise according to the
planned flexible training program. However, small ad-
justments to the exercises can be individually modified
to achieve a better adherence to the planned exercise
intervention. For instance, if the participant has muscu-
loskeletal system disabilities that preclude planned exer-
cises, these are replaced with a more suitable one that
differs from the original as little as possible. The
modifications are suggested by the personal trainer and
approved by the researchers.
Endurance training Endurance training can be imple-
mented in many ways, such as running, cycling, swim-
ming or rowing. The participant is allowed to choose the
most suitable forms of exercise and the participant is
free to switch between different forms of training. En-
durance training is performed twice a week and moni-
tored by a heart-rate monitor (Polar A370, Polar,
Finland). The duration and the intensity of the training
increases progressively (Table 1).
High Intensity Interval Training (HIIT) High intensity
interval training (HIIT) consisting of circuit type train-
ing, cross-training and uphill−/stair-running is per-
formed once a week. HIIT includes three different
exercise sessions that change every 2 weeks (Table 1.).
The idea in HIIT is to perform short exercise bouts with
very high intensity with recovery periods in between.
Resistance training Resistance training (RT) is per-
formed once a week and the loads correspond to ap-
proximately 75% of the external load that can be lifted
once i.e. one repetition maximum (1 RM) throughout
the training period. The training program includes both
upper and lower body exercises at each session (Table
1). The initial training loads for different training phases
and specific exercises are determined at weeks 1, 10 and
20. The exercises become more challenging as the inter-
vention progresses, if the participant’s development and
body control allows.
The adherence of the participants to the exercise inter-
ventions are monitored using heart rate monitors (Polar
A370, Polar, Finland). The participants are asked to up-
load the heart rate monitor data into the PolarFlow
cloud service periodically. In addition, participants are
provided with an exercise diary to record all completed
exercises and their dates. Missed exercises and their
causes are also recorded in the diary. Based on the exer-
cise diary and heart rate monitor data, the researchers
assess whether a sufficient proportion of the exercises
have been completed. The study participants are not
allowed to participate in another concurrent interven-
tional clinical trial during the study period.
Personal training
Study participants live in different parts of Finland, and
therefore the exercise intervention is performed at the
participants’ local gym and cannot be supervised by the
CROSSYS research group per se. The gyms are chosen
according to the participants’ preference as well as
evaluation of the gym facilities. The selection criteria for
gyms includes comprehensive gym equipment and
Fig. 2 Recruitment of the monozygotic twin pairs from three twin
cohorts (FinnTwin12, FinnTwin16 and older cohort) as well as their
estimated participation and drop-out rates. MZ: monozygotic, T2D:
type 2 diabetes
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personal trainer services, as the study’s personal trainers
are recruited through selected gyms. Personal trainers
are introduced to research and exercise intervention on
a phone conversation and are given written instructions
regarding the training period. In addition, they receive
the necessary information regarding the participants’
background and possible limitations that need to be
taken into account when planning the individually tai-
lored exercise program. Personal trainers’ main role is to
motivate the participants to stick with the planned exer-
cise intervention and to supervise the participants to
conduct the exercises as they were planned with a
proper technique to avoid injuries. Personal trainers are
also advised on what to do, for example, if the partici-
pant becomes ill or has to cancel training. Personal
trainers are also advised to contact the research team if
anything unexpected or abnormal happens.
Outcome measures
Euglycemic hyperinsulinemic clamp and FDG-PET study
Tissue-specific insulin-stimulated glucose uptake is one
of the primary outcome measures in this study. It is
studied with a radio tracer 2-deoxy-2-[18F]fluoro-D-glu-
cose (FDG) by PET. FDG is a glucose analogue that is
transported into cells similarly as glucose. In a cell, FDG
is phosphorylated, which prevents its further metabolism
and it is therefore trapped within the cell until it decays
and emits photons that are detected by the PET scanner
[39]. In the present study FDG-PET scan is performed
during an euglycemic hyperinsulinemic clamp [40] that
is a method to measure whole-body insulin-stimulated
glucose uptake (M-value). This value is considered to be
the most definitive measure of insulin sensitivity in
humans and is another primary outcome measure of this
study [41].
Participant is required to fast overnight (at least 10 h)
and to avoid excess physical activity for 48 h before the
FDG-PET study. Before the euglycemic hyperinsulinemic
clamp and the PET study protocol, the antecubital veins
from both arms are cannulated. One of the two catheters
is used for the administration of glucose and insulin dur-
ing the clamp study and injection of the PET tracer. The
other catheter is used to obtain venous blood samples
during the study. The arm used to obtain blood samples
is heated with an electrically powered cushion for the
whole duration of the study to “arterialize” the venous
blood. The participant is positioned in a supine position
and instructed not to move and avoid muscle contrac-
tion throughout the whole study protocol.
The euglycemic hyperinsulinemic clamp is performed
as originally described by DeFronzo et al [41]. A primed-
constant insulin (Actrapid 100 U · ml− 1, NovoNordisk,
Bagsvaerd, Denmark) infusion is started with the rate of
40 mU per square meter of body surface area in minute
(mU·m− 2·min− 1) during the first 4 min. Then, the infu-
sion rate is reduced to 20mU·m− 2·min− 1 for the time
interval 4–7min. After 7 min, the infusion rate is further
reduced to 10 mU·m− 2·min− 1 for the rest of the clamp.
Exogenous glucose infusion is started 4min after the
start of the insulin infusion with a rate of [participant’s
mass (kg)·0.5]g·h− 1. At the 10-min time point, glucose
infusion is doubled and after that further adjusted ac-
cording to blood glucose concentration aiming at the
steady level of 5 mmol·l− 1. Arterialized venous blood
samples are collected before the clamp and every 5 min
during the entire clamp to determine the glucose con-
centration for adjusting the glucose infusion rate. M-
value is calculated from the glucose values obtained in
the steady state of 5 mmol·l− 1 lasting at least 20 min
[41].
After 60 min of insulin clamp, a participant is posi-
tioned in a supine position into the PET scanner (Dis-
covery MI (DMI), GE Healthcare, US), while all
unnecessary movement and muscle activity of the par-
ticipant is avoided during the transition. Tissue-specific
insulin-stimulated glucose uptake is measured using
FDG as a radio tracer, which is produced according to
Hamacher et al. [42]. The tracer [150MBq] is injected to
the antecubital vein via a catheter approximately 80–90
min after the start of the euglycemic hyperinsulinemic
clamp when the stable glucose concentration of 5
mmol∙l− 1 (±0.5) is reached. Once the tracer is injected
to the participant, scanning is started immediately. The
scanning protocol starts from brain and lasts for 40 min
in 4 × 30 s, 3 × 60 s, and 7 × 300 s time frames. Then, the
scanning proceeds to thoracic, abdominal and femoral
regions for 9 min in 3 × 180 s time frames for each of
these three regions. Blood samples for plasma radioactiv-
ity determination (Wizard 1480 Automatic Gamma
Counter, Perkin-Elmer) and calculation of input function
are collected at 30, 45, 60, 75, 90 s, and 2, 2.5, 3, 3.5, 4,
4.5, 5, 10, 15, 20, 30, 35 min after the injection of the
tracer during the brain scan and once at 4.5 min during
each of the consecutive three 9-min scans (thoracic, ab-
dominal and femoral region scans). Euglycemic hyperin-
sulinemic clamp is continued throughout the FDG-PET
scan, and blood glucose levels are monitored by taking
blood samples every 5 min.
During the FDG-PET study, blood samples for lactate
are collected at time points 0, 20, and 80min, for insulin
at 0, 30, 60, 90, 120, and 150 min, and for free fatty acids
at 0, 60 and 120 min. These samples are collected to en-
sure that the clamp is performed successfully.
All obtained PET image raw files are corrected for at-
tenuation, dead time, and decay. Images are reconstructed
using the block sequential regularized expectation
maximization (BSREM) algorithm with BETA factor 150
for the brain and 350 for thoracic, abdominal and femoral
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regions. Images are analysed using Carimas software that
has been produced in house (www.turkupetcentre.fi/
carimas).
PK11195-PET
Neuroinflammation is another outcome measure in this
study and studied using PET imaging with a 11C-labelled
R isomer of [1-(2-chlorophenyl)-N-methyl-N-(1-methyl-
propyl)-3-isoquinolinecarboxamide] ([11C]-(R)-
PK11195), which binds to the 18-kDA translocator pro-
tein (TSOP) [43]. TSOP is upregulated in activated
microglial cells and macrophages associated with neuro-
inflammation, but is expressed at low level in resting
microglia [44]. Thus, [11C]-(R)-PK11195 can be used as
a marker of inflammation specifically in brain.
PK11195-PET study is performed after a light meal. Be-
fore the PK11195-PET study, antecubital vein of the left
hand is cannulated and fed-state blood samples for C-
reactive protein and microglial cell quantification is taken
in order to study possible correlations between these in-
flammation markers and PK11195-PET imaging results.
The participant is then positioned into the PET scan-
ner (Discovery MI (DMI), GE Healthcare, US), in supine
position with the brain in the scanning area of the gan-
try. The PET/computed tomography (CT) scanner used
in the PK11195-PET study is the same scanner used in
the FDG-PET study. Once the tracer of 350MBq is
injected into the vein, the scanning is started immedi-
ately and continued for 60 min in 2 × 15 s, 3 × 30 s, 3 ×
60 s, 7 × 300 s, and 2 × 600 s time frames. Blood samples
are not taken during the PK11195-PET scan. Images are
reconstructed using the BSREM algorithm with BETA
factor 350.
Magnetic resonance imaging and magnetic resonance
spectroscopy
Magnetic resonance imaging (MRI) and proton magnetic
resonance spectroscopy (MRS) studies are performed in
the evening approximately four h after the lunch. Partici-
pants have a small snack before the study. The imaging
is performed with Siemens Magnetom Skyra fit 3 T MRI
system (Siemens Healthcare, Erlangen, Germany). MRI
is performed in five parts as detailed below. Participants
are allowed to have a break between the parts when
necessary.
At first, the brain MRI is performed with a Siemens
Head/Neck 20 channel coil, including brain morphology
and the resting state functional MRI (fMRI) sequences.
The brain protocol consists of six sequences as listed in
Table 2 (localizer not listed). The resting state fMRI with
eyes open is acquired twice.
Secondly, a whole-body imaging is performed in order
to define volume of adipose tissue in abdominal and
femoral regions as well as volume of the liver and the
pancreas. At first, a rapid whole-body localizer image is
acquired using a FastView sequence utilizing a continu-
ously moving table (table speed 46 mm·s− 1). Then, T1
VIBE Dixon images are acquired in five substeps which
are 200 mm apart from each other (center to center).
The general parameters of the series after the localizer
sequences are listed in Table 3. A combination of Spine
32, Head/Neck 20, Body 30, Body 18 and Peripheral
Angio 36 coil is used for signal acquisition.
The third object is the heart, where pericardial fat vol-
ume is determined as well as the fat content within the
septum by using MRS. The heart MRI protocol consists
of 9 sequences as detailed in Table 4 (localizer sequences
not listed) using a combination of Siemens Body 30 and
Spine 32 coils. The first five sequences are used for posi-
tioning and planning of the two cine sequences to ac-
quire them in four-chamber and short-axis orientations.
T2 Haste sequence is used for positioning the breathing
navigator voxel for the T1 turbo spin echo (TSE) dark
blood sequence which is acquired for the analysis of
pericardial fat volume. All sequences are acquired under
breath holds. All but the T2 Haste and localizer are ECG
triggered. In the cine sequences 30 frames were acquired
in one ECG R-R interval.
The fourth imaging region is the abdomen (Table 5,
localizer sequences not listed), in which the fat content
within the pancreas and the liver is determined by MRS
using Spine 32, Siemens Body 30 and Siemens Body 18
coils. Finally, the fifth object is the tibialis anterior
muscle measured with QED TxRx 15 channel knee coil
(Table 6, localizer sequences not listed), in which intra-
and extramyocellular lipid content is measured by MRS.
Two MRS spectra are acquired from each organ (heart,
pancreas, liver, tibialis anterior): one with water suppres-
sion and another without water suppression. For the
heart, delay for the ECG trigger is adjusted for each
participant, typical value being 210 ms. The general se-
quence parameters for MRS are listed in Table 7.
Transthoracic echocardiography
Complete two-dimensional (2D), color, pulsed and
continuous-wave Doppler echocardiogram is performed
according to standard techniques. Conventional left-
ventricular (LV) systolic function is measured with 2-
and 4-chamber apical views (Simpson’s biplane method
of discs, corrected for body surface area). LV end-
diastolic volume index (EDVI), LV end-systolic volume
index (ESVI) and LV ejection fraction (LVEF) are calcu-
lated. LV mass index is calculated using the area-length
method as recommended by the American Society of
Echocardiography and corrected for body surface area
[45]. Advanced LV systolic function parameters are mea-
sured with tissue Doppler imaging (TDI). Peak systolic
tissue velocities are derived from septal and lateral
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pulsed wave and color coded TDI. Speckle tracking de-
rived strain parameters are obtained from apical 4,2 and
3-chamber views [46].
Conventional LV diastolic function parameters are de-
rived from 2- and 4-chamber views [47]. Maximum left
atrium (LA) volume is derived with discs method, cor-
rected for body surface area. Pulsed wave Doppler vel-
ocities are measured from the apical 4-chamber view
using a 2 mm sample volume positioned at mitral leaflet
tips. Transmitral early (E wave) and late (A wave) dia-
stolic velocities are measured as well as E wave deceler-
ation time. Pulsed wave TDI of the lateral and septal
mitral annulus are used to measure E’.
Bone density
Quantitative computed tomography (QCT) is used to
measure bone mineral density using Discovery MI com-
puted tomography (CT) scanner (GE Healthcare, Wau-
kesha, WI, US) with a solid Mindways QCT Phantom
(Mindways Software Inc., Austin, TX, US, model QCT
Pro) immediately after the FDG-PET scan [48]. Verte-
brae L2 to L4 are scanned in the supine position.
Calibration phantom is used to convert Hounsfield Units
into bone mineral equivalents in mg · cm− 3 using QCT
Pro software (Mindways Software Inc., Austin, TX,
USA), with which the CT images are analyzed [49].
Blood samples
During the visits 1 and 3 (Fig. 1), blood samples are ob-
tained in a fasted state (10 h) in the morning. From the
samples complete blood count, glycated hemoglobin
(HbA1c), lipid profiles, liver enzymes and C-reactive pro-
tein are determined. Before the FDG-PET study (visits 2
and 4 in Fig. 1), fasting state blood samples are collected
and stored in a freezer (− 70 °C) for further analyses.
Oral glucose tolerance test
A 2-h oral glucose tolerance test (OGTT) is performed
after at least a 10-h fast during the visits 1 and 3. (Fig.
1). After ingestion of 250 ml of liquid containing 75 g of
glucose (GlucosePro, Comed Oy, Ylöjärvi, Finland),
blood samples are collected at baseline, 15, 30, 45, 60,
90, and 120 min during the test to determine glucose, C-
peptide, and insulin concentrations in the blood.
Muscle and adipose tissue samples
Muscle and adipose tissue biopsies are collected at the
end of the PET imaging visit in a post-prandial state.
Subcutaneous adipose tissue is collected from the right
side of the lower abdomen and the lateral side of the
right thigh using open surgical procedure. After the se-
lected skin area is sterilized and local anesthetic (lido-
caine supplemented with epinephrine) administered, a
small incision is made from which the adipose tissue
sample is extracted with a sharp knife and anatomical
forceps. Muscle biopsy is collected from the vastus later-
alis muscle inferior to trochanter major and anterior to
lateral fascia using suction-modified Bergström muscle
biopsy technique [50] from the same cut as the femoral
adipose tissue sample. Post-intervention tissue samples
are collected as near to the locations of the baseline
samples as possible, avoiding the scars. One part of the
biopsies is flash frozen in liquid nitrogen and stored at
freezer (− 70 °C). The other part is put in formalin and
subsequently embedded in paraffin. The incisions are
closed with absorbable sutures.
Faeces and urine samples
Faeces and urine samples are collected at the first PET im-
aging visit to determine gut microbiota and metabolomics,
respectively, midway through the training intervention,
and at the last PET imaging visit. The participants fill out
a 3–4 day food diary before giving the faeces sample. The
samples are stored in a freezer (− 70 °C) prior to a total
DNA extraction and further analysis.
Total DNA will be extracted from the fecal material
(approx. 100–200mg) using a commercial DNA extrac-
tion Kit following the manufacturer’s instructions. DNA
concentration will be measured using Qubit® 2.0
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Fluorometer (Life Technology, Carlsbad, CA, US) for fur-
ther analysis.
DNA libraries will be performed with the amplification
of the Specific 16S ribosomal RNA (rRNA) gene region
(V3-V4) following Illumina protocols. A multiplexing
step will be conducted by the NextEra XT Index Kit
(Illumina, San Diego, CA, United States). 16S amplicons
will be confirmed and checked with a Bioanalyzer DNA
1000 chip (Agilent Technologies, Santa Clara, CA,
United States). Libraries will be sequenced on Illumina
platform according to manufacturer instructions. During
DNA extraction and PCR amplification, the reagent con-
tamination is controlled and ruled out by using blanks
not containing a sample.
Quality-trimmed and filtering will be assessed using
DADA2 pipeline. Taxonomic assignment will be con-
ducted using the Silva v132 database. Samples with less
than 1000 reads will be removed from the final analysis.
Sequences not assigned to Bacteria domain level, also,
those sequences classified as cyanobacteria and chloro-
plasts, likely represent ingested plant material, will be re-
moved from the dataset.
Neuropsychological test battery
Neuropsychological function is assessed by an online
survey using Gorilla Experiment Builder (gorilla.sc) plat-
form [51]. The survey consists of several tasks that
measure working memory (N-back tasks with N = 1 and
N = 2, digit span text entry), memory encoding and re-
trieval with CERAD Word List Memory task type test,
vigilance, simple reaction time, and fluid intelligence
with The matrix reasoning item bank (MaRs-IB) [52]
which is a modified open-source variant of the Raven’s
progressive matrices test. Emotional sensitivity was mea-
sured by asking subjects to report their feelings of
valence (pleasure-displeasure) and arousal to a set of
pleasant, unpleasant and neutral pictures derived from
the International Affective Picture system (IAPS) [53,
54]. The survey is performed after the lunch during an
afternoon of a PET study day in a quiet room using a
standard desktop computer.
Physical activity questionnaire
Habitual physical activity is assessed using a question-
naire by Baecke et al. [55] before and after the exercise
intervention period. It consists of 16 questions divided
into three sections: physical activity at work, during leis-
ure time (sport excluded) and during sport. Three indi-
ces measuring the level of habitual physical activity are
calculated (work, leisure and sport index). The question-
naire is performed as an in-person interview conducted
by a researcher during a PET study day.
Body composition, maximal exercise capacity and muscular
strength
Body composition measurements, a maximal oxygen up-
take (VO2max) exercise test and tests for muscular
strength are performed to each participant before and
after the training intervention. The tests are performed
at the Paavo Nurmi Centre (Turku, Finland).
Participants’ body composition is measured using a
bioimpedance analysis machine (Inbody 720; Biospace
Co, Korea). The machine measures participants’ total
mass, skeletal muscle mass, body fat mass, body mass
index, body fat percentage, and the lean mass balance
between left and right arm, left and right leg and the
trunk.
VO2max is measured using a stationary bicycle ergom-
eter (Ergoline 800 s; VIASYS Healthcare, Germany). For
men, the test starts with 50W which is increased by 30
W every 2 min until volitional exhaustion. For women,
the test starts with 40W which is increased by 20W
every 2 min until volitional exhaustion. Ventilation and
gas exchange (Jaeger Oxycon Pro; VIASYS Healthcare or
Vyntus CPX, Vyaire Medical Gmbh, Leibnizstrasse,
Hoechberg, Germany) are measured during the test. The
PRE and POST test for each pair is conducted using the
same device. Participants’ blood lactate concentration is
measured from capillary samples immediately and 1min
after exhaustion (YSI 2300 Stat Plus; YSI Incorporated
Life Sciences, Yellow Springs, OH). The heart rate of the
participants is followed continuously with an ECG-
machine (CardioSoft GE, CardioSoft V6.51; GE Medical
Systems Information Technologies, USA).
Muscle strength is tested using repetition tests for sit-
ups, back extensions, and dumbbell overhead press. Max-
imal grip strength of the dominant hand and indirect test
for vertical jump height are also performed. For abdom-
inal muscle strength, participants perform as many repeti-
tions of abdominal crunches as possible in a 30 s time
frame. The participants lie on their back in an ab bench
with legs fixed into a 90° knee angle, hold hands behind
the neck and point elbows forward. Participants’ elbows
and knees must touch every repetition. The back strength
is measured with a Roman chair with added metal rods
that form a 90° angle. Participants perform back exten-
sions with hands behind the neck and elbows pointing dir-
ectly to the sides as many repetitions as possible in a 30 s
time frame. During one repetition participants’ elbows
must hit both the upper and the lower metal rods. Arm
strength is measured with a standing dumbbell overhead
press test. The mass of the dumbbells used during the test
are 10 kg for men and 5 kg for women. The aim of the test
is to get as many repetitions as possible alternating arms
every repetition. Participants are allowed to use only their
stronger arm in the end of the test, if a failure in the con-
centric phase for the weaker arm occurs, in order to
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conduct as many repetitions as possible. Once the partici-
pant has chosen to use only one arm, he or she cannot
use the other arm during the test. Maximal grip strength
is measured with a computerized digital dynamometer
(GOOD STRENGTH dynamometer Metitur Oy, Jyväs-
kylä, Finland). Participants may choose which arm they
use for the test. Explosive leg muscle strength is assessed
from a vertical counter-movement jump height that is in-
directly calculated from the flight time that is recorded by
a led-light beam system (OptoJump Next; Microgate,
Italy). Participants are instructed to hold their hands at
the waist to nullify the effect of the arms during a
countermovement-jump. Participants jump 3–5 times and
the average of the three best flight times is used to calcu-
late the jump height.
Statistical analysis and modelling
Power calculation
The sample size calculations are based on liver fat content
and VO2max results from the earlier cross-sectional study
in twins discordant for physical activity and fitness [56,
57], and on M-value [58]. The data will be analyzed with
hierarchical linear mixed model which take into account
the correlation between repeated measurements and
twins. Model will at least include training as categorical
factor and time as within factor. It will be investigated
whether there are significant change in mean values over
time (training effect) and whether training effect is differ-
ent between the heavier and the leaner twins.
For the VO2max, to test the effectiveness of the interven-
tion, the evaluated sample size is calculated using the
mean VO2max value for the less active twins [57]. Standard
deviation (SD) between twin pair measurements was 2.8
and correlation between measurements over 0.93. With
these assumptions we wanted to evaluate the sample size
needed to detect a 5–10% mean difference. Due to high
correlation, the sample size needed for a 5% mean differ-
ence is 6 twin pairs. For a greater mean difference than
5%, the sample size would be even lower. The correspond-
ing values for liver fat content are 2.1%, SD 1.39, and cor-
relation over 0.98 and due to high correlation, the sample
size needed for a 20% mean difference is 22 twin pairs
[56]. These values for the whole-body insulin sensitivity
are 6.2 mg/kg fat-free mass/min, SD 0.3, and correlation
over 0.7, and the sample size needed to detect 30% mean
difference is 6 twin pairs [58].
According to these calculations, at least 22 pairs is
needed for the study. We are unable to calculate the
sample size for all the main parameters due to non-
existing twin data. However, we believe that the same
schema will hold true in the other main parameters due
to the high correlation of twins and small variation
within the twin pairs.
Statistical analysis
The data is first evaluated visually based on standard
techniques including quantile-quantile plots and histo-
grams to detect possible outliers and to assess the nor-
mality. Normality is also evaluated using Shapiro-Wilk
test and logarithm or other statistical transformations
are performed when appropriate. The data is also ana-
lyzed for possible dimensionality reduction using stand-
ard methods such as principal component analysis.
Statistical analyses are performed using hierarchical
mixed linear models. The models include two within-
factors: time (before and after intervention) and twin
(heavier and leaner co-twin), and their interaction term
(time x twin). Medications, adherence to the exercise
intervention, sex, age, BMI and other factors are in-
cluded in the models when appropriate. The potential
covariates will be screened for association, and covari-
ates that do not show significant association with the re-
sponse variable will be excluded from the analysis.
When the number of participants allows it, we will carry
out separate subgroup analyses by sex, age (two younger
cohorts vs. older cohort), and/or mass (obese vs. non-
obese participants). Subjects with missing data points
are included in the statistical analysis by using the re-
stricted maximum likelihood estimation within the linear
mixed models. Hence, model-based means and 95% con-
fidence intervals are reported.
Correlation analysis are performed using Pearson’s
product-moment correlation coefficient for normally
distributed data and Spearman’s rank correlation coeffi-
cient for non-normally distributed data. All statistical
tests are performed as two-sided and p-values less than
0.05 will be considered as statistically significant.
Discussion
This study allows the investigation of the brain, periph-
eral tissues, and gut microbiota using sophisticated bio-
medical imaging technology, clinical and physiological
measures combined with multiple omics. The study will
reveal new knowledge of the systemic pathophysiological
effects of obesity, insulin resistance and T2D and investi-
gates, whether exercise training can alleviate or even re-
verse these pathophysiological changes.
The benefits of exercise training and the effects of
physical inactivity on the whole-body metabolism and
health are generally and widely accepted [59, 60]. How-
ever, the health benefits of exercise training are often
studied using epidemiological studies or cross-sectional
studies comparing persons with varying levels of physical
activity. The participants in previous studies range from
sedentary participants to even elite athletes, while well-
planned long-term interventional studies are not very
common. In previous cross-sectional studies of MZ pairs
discordant for exercise, we see differences in
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cardiorespiratory fitness [57, 61], body adiposity [56, 61,
62], metabolic parameters [63, 64] and diabetes risk [65,
66] but not in overall mortality [67]. These observational
studies permit demonstration of associations, but do not
provide strong evidence for causality. Studies with exer-
cise interventions are generally quite short-term with
genetically controlled interventional studies being rare.
Nonetheless, given genetic influences on both responses
to exercise and metabolic outcomes [11, 19], confound-
ing by genetic factors is a major potential source of bias.
In the CROSSYS study, the exercise training consists of
6-month-long progressive program that is designed to
be realistic in every-day life and is consistent with the
current Finnish exercise recommendations. Hence, the
exercise program used in this study can be translated
into the real-life settings.
The eminent strength of the study is the possibility to
study MZ twin pairs discordant for BMI. The co-twin-
pairs share a similar genome at sequence level that
enables us to study the effects of obesity and insulin re-
sistance in conjunction with long-term exercise training
without the confounding effects of genetic variation. All
of the twins to be recruited in CROSSYS have partici-
pated in previous twin studies in the University of
Helsinki. This enables us to use longitudinal data on the
development of the obesity and the changes in habitual
physical activity of the twins [38, 68]. Another great
strength of the present study is the use of state-of-the-
art medical imaging technologies, which makes it pos-
sible to study tissue-specific metabolism (brain, heart,
liver, pancreas, intestine, bone, adipose and muscle tis-
sues) and brain function in detail.
The potential limitation of the study is that the ob-
served changes may reflect changes in the diet. In the
present study, we aim to investigate the effects of exer-
cise, and we ask the participants not to change their diet
during the 6-month-long exercise intervention. We also
advice the personal trainers to help the participants to
maintain their diet and to avoid the increase of energy
intake that often occurs when an untrained person starts
to exercise [69]. On the other hand, we do not wish the
participants to lose excessively mass due to reduced en-
ergy intake. To assess dietary habits during the course of
the intervention, the participants fill out a food diary in
the beginning, middle, and end of the intervention. An-
other possible limitation of the study may be a variation
in the exercise training adherence. The major role of the
personal trainers is to provide encouragement and sup-
port to the study participants. In addition, the re-
searchers monitor the training adherence via PolarFlow
service. However, it is expected that there are differences
in the training adherence, and this will be taken into ac-
count when analyzing the results. The third limitation
are the missing data points that are expected to occur
due to problems in PET tracer production, malfunction
of the imaging equipment, and other unforeseen events.
To alleviate this major problem, missing data points are
taken into account by restricted maximum likelihood es-
timation within the linear mixed models.
Trial status
Ongoing. The first participants were enrolled in January
2019. The estimated date of the completion of the data
collection is December 2021.
Abbreviations
BMI: Body mass index; BSREM: Block sequential regularized expectation
maximization; CT: Computed tomography; ECG: Electrocardiography;
EDVI: End-diastolic volume index; ESVI: End-systolic volume index; FDG: 2-
deoxy-2-[18F]fluoro-D-glucose; fMRI: Functional magnetic resonance imaging;
GWAS: Genome wide association study; HbA1c: Glycated hemoglobin;
HIIT: High intensity interval training; IAPS: International Affective Picture
system; LA: Left atrium; LV: Left ventricle/ventricular; LVEF: Left-ventricular
ejection fraction; MaRs-IB: Matrix reasoning item bank; MRI: Magnetic
resonance imaging; MRS: Magnetic resonance spectroscopy; M-value: Whole-
body insulin-stimulated glucose uptake; MZ: Monozygotic (twins); OGTT: Oral
glucose tolerance test; PCR: polymerase chain reaction; PET: positron
emission tomography; PK11195: [1-(2-chlorophenyl)-N-methyl-N-(1-
methylpropyl)-3-isoquinolinecarboxamide]; QCT: Quantitative computed
tomography; rRNA: Ribosomal RNA; SD: Standard deviation; T2D: Type 2
diabetes; TDI: Tissue Doppler imaging; TSE: Turbo spin echo; TSOP: 18-kDA
translocator protein; VO2max: Maximal oxygen uptake; WHO: World Health
Organization; 1RM: (External load that can be lifted once i.e. one repetition
maximum); 2D: Two-dimensional
Acknowledgements
The authors thank the staff of Turku PET Centre and Paavo Nurmi Centre,
University of Turku, for their excellent assistance in the study. The authors
thank radiographer Ekaterina Saukko, PhD (Department of Radiology, Turku
University Hospital, Turku, Finland) for her invaluable assistance and expertise
in conducting the MRI scans in the study.
Confidentiality
All the obtained data will be pseudo-anonymized and the participants will
receive a study ID. The results will be reported as means. The printed docu-
ments containing data will be stored in locked facilities and the access to
the electronical data storage will require personal credentials.
Provisions
The participants will receive a study compensation according to the Finnish
law (82/2011, 1–3 §) for the participation in the study. In addition, all the
travelling and accomodation expenses will be compensated for the study
participants.
Dissemination policy
The data obtained from the CROSSYS-study will be published in international
peer-reviewed high impact journals. In addition, the study participants will
receive a personal feedback-letter, in which selected variables are reported
and explained.
Authors’ contributions
JCH, TM, and LL designed the study. MAH and SMH planned the exercise
training protocol. KK, VS and JS constructed the MRI and MRS protocols. JCH
and JOR constructed the PET protocols. RL designed and performs the
echocardiography. JOR and LN designed the neuropsychological test battery
and LN developed the online test platform. MCC is involved in the planning
of fecal samples analysis. JCH, MAH and EL are involved in data collection
planning and MAH, EL and LL in statistical data analysis planning. MAH, JH,
JK and KHP recruit the participants. MAH, JH, SMH and RO are responsible
for coordinating the intervention study. MAH, JH, SMH, RL, MH, KK, RO and
MSL collect the data. MAH drafted the first version of the manuscript with
input from all authors. All authors critically reviewed the manuscript and
Heiskanen et al. BMC Sports Science, Medicine and Rehabilitation           (2021) 13:16 Page 17 of 19
approved the final version. JCH is the guarantor of this work and takes
responsibility for the integrity of the data and the accuracy of the data
analysis.
Funding
The study is financially supported by the Academy of Finland (JCH decision
317332, KHP decisions 272376, 314383, 266286, and LL decision 295741), the
Finnish Cultural Foundation (JCH, MAH, KHP), the Diabetes Research
Foundation of Finland (JCH, MAH), the Juho Vainio Foundation (MAH), Novo
Nordisk Foundation (KHP, NNF17OC0027232, NNF10OC1013354), Helsinki
University Hospital (KHP), Government Research Funds (KHP), Finnish Medical
Foundation (KHP), Gyllenberg Foundation (KHP), Sigrid Juselius Foundation
(KHP), and University of Helsinki (KHP). The funders will not have any role in
the study design, collection, analysis, and interpretation of the data and
reporting of the findings.
Availability of data and materials
The dataset generated and analysed during the current study are not
publicly available in order to protect the individual privacy but are available,
once the whole dataset is collected, from the corresponding author on
reasonable request for researchers who have institutional review board/
ethics approval and an institutionally approved study plan.
Ethics approval and consent to participate
Study protocol, patient information, and informed consent are approved by
the Ethical Committee of the Hospital District of South-Western Finland (de-
cision 100/1801/2018 §438). The study is conducted according to Good Clin-
ical Practice and the Declaration of Helsinki. The participants receive the
detailed study protocol and it is explained both orally and in written text
that the participation to the study is voluntary and they have the right to
withdraw from the study at any time without explaining the reason. Written
informed consent for the study is obtained from all participants before the
beginning of the study.
Consent for publication
The results will be presented as means ± SD in order to maintain
anonymousity.
Competing interests
None. The study has not received funding/assistance from a commercial
organization.
Author details
1Turku PET Centre, University of Turku, P.O. Box 52, FIN-20521 Turku, Finland.
2Heart Centre, Turku University Hospital, Turku, Finland. 3Department of
Medical Physics, Turku University Hospital, Turku, Finland. 4Division of
Digestive Surgery and Urology, Turku University Hospital, Turku, Finland.
5Department of Biostatistics, University of Turku, Turku, Finland. 6Department
of Psychology, University of Turku, Turku, Finland. 7Institute of Agrochemistry
and Food Technology-National Research Council (IATA-CSIC), Valencia, Spain.
8Functional Food Forum, University of Turku, Turku, Finland. 9A.I. Virtanen
Institute for Molecular Sciences, University of Eastern Finland, Kuopio,
Finland. 10Department of Future Technologies, University of Turku, Turku,
Finland. 11Obesity Research Unit, Research Program for Clinical and Molecular
Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
12Abdominal Center, Obesity Center, Endocrinology, University of Helsinki
and Helsinki University Central Hospital, Helsinki, Finland. 13Institute for
Molecular Medicine Finland FIMM, HiLIFE, University of Helsinki, Helsinki,
Finland. 14Turku PET Centre, Turku University Hospital, Turku, Finland.
Received: 28 January 2021 Accepted: 3 February 2021
References
1. Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. Lancet. 2017;389:2239–
51. https://doi.org/10.1016/S0140-6736(17)30058-2.
2. Hruby A, Hu FB. The epidemiology of obesity: a big picture.
Pharmacoeconomics. 2015;33:673–89.
3. Petersen MC, Shulman GI. Mechanisms of insulin action and insulin
resistance. Physiol Rev. 2018;98:2133–223. https://doi.org/10.1152/physrev.
00063.2017.
4. van Herpen NA, Schrauwen-Hinderling VB. Lipid accumulation in non-
adipose tissue and lipotoxicity. Physiol Behav. 2008;94:231–41.
5. Deem JD, Muta K, Scarlett JM, Morton GJ, Schwartz MW. How should we
think about the role of the brain in glucose homeostasis and diabetes?
Diabetes. 2017;66:1758–65.
6. Lam CK, Chari M, Lam TK. CNS regulation of glucose homeostasis. Physiol.
2009;24:159–70.
7. Parton LE, Ye CP, Coppari R, Enriori PJ, Choi B, Zhang CY, et al. Glucose
sensing by POMC neurons regulates glucose homeostasis and is impaired
in obesity. Nature. 2007;449:228–32.
8. Brown JM, Scarlett JM, Michael W, Brown JM, Scarlett JM, Schwartz MW.
Rethinking the role of the brain in glucose homeostasis and diabetes
pathogenesis. J Clin Invest. 2019;129:3035–7.
9. Tremaroli V, Bäckhed F. Functional interactions between the gut microbiota
and host metabolism. Nature. 2012;489:242–9.
10. Tilg H, Zmora N, Adolph T, Elinav E. The intestinal microbiota fuelling. Nat
Rev Immunol. 2019; Epub ahead of print.
11. Bouchard C, Rankinen T, Timmons JA. Genomics and genetics in the
biology of adaptation to exercise. Compr Physiol. 2011;1:1603–48.
12. Bouchard C, Antunes-Correa LM, Ashley EA, Franklin N, Hwang PM,
Mattsson CM, et al. Personalized preventive medicine: genetics and the
response to regular exercise in preventive interventions. Prog Cardiovasc
Dis. 2015;57:337–46. https://doi.org/10.1016/j.pcad.2014.08.005.
13. Sarzynski MA, Ghosh S, Bouchard C. Genomic and transcriptomic predictors
of response levels to endurance exercise training. J Physiol. 2017;595:2931–
9. https://doi.org/10.1113/JP272559.
14. Ali O. Genetics of type 2 diabetes. World J Diabetes. 2013;4:114–23.
15. Naukkarinen J, Rissanen A, Kaprio J, Pietiläinen KH. Causes and
consequences of obesity: the contribution of recent twin studies. Int J Obes.
2012;36:1017–24. https://doi.org/10.1038/ijo.2011.192.
16. Willemsen G, Ward KJ, Bell CG, Christensen K, Bowden J, Dalgård C, et al.
The concordance and heritability of type 2 diabetes in 34,166 twin pairs
from international twin registers: the discordant twin (DISCOTWIN)
consortium. Twin Res Hum Genet Off J Int Soc Twin Stud. 2015;18:762–71.
17. Sanghera DK, Blackett PR. Type 2 diabetes genetics: beyond GWAS. J
Diabetes Metab. 2012;3(198):6948. https://doi.org/10.4172/2155-6156.10001
98.
18. Solomon TPJ, Malin SK, Karstoft K, Haus JM, Kirwan JP. The influence of
hyperglycemia on the therapeutic effect of exercise on glycemic control in
patients with type 2 diabetes mellitus. JAMA Intern Med. 2013;173:1834–6.
https://doi.org/10.1001/jamainternmed.2013.7783.
19. Solomon TPJ. Sources of inter-individual variability in the therapeutic
response of blood glucose control to exercise in type 2 diabetes: going
beyond exercise dose. Front Physiol. 2018;9:896 https://www.frontiersin.
org/article/10.3389/fphys.2018.00896.
20. Stephens NA, Sparks LM. Resistance to the beneficial effects of exercise in
type 2 diabetes: are some individuals programmed to fail? J Clin Endocrinol
Metab. 2015;100:43–52. https://doi.org/10.1210/jc.2014-2545.
21. Boulé NG, Weisnagel SJ, Lakka TA, Tremblay A, Bergman RN, Rankinen T,
et al. Effects of Exercise Training on Glucose Homeostasis. Diabetes Care.
2005;28:108 LP–114. https://doi.org/10.2337/diacare.28.1.108.
22. Sahu M, Prasuna JG. Twin studies: a unique epidemiological tool. Indian J
Community Med. 2016;41:177–82. https://doi.org/10.4103/0970-0218.183593.
23. Handschin C, Spiegelman BM. The role of exercise and PGC1α in
inflammation and chronic disease. Nature. 2008;454:463–9.
24. Sjöros T, Heiskanen MA, Motiani KK, Löyttyniemi E, Eskelinen J-J,
Virtanen KA, et al. Increased insulin-stimulated glucose uptake in both
leg and arm muscles after sprint interval and moderate intensity
training in subjects with type 2 diabetes or Prediabetes. Scand J Med
Sci Sports. 2018;28:77–87.
25. Heiskanen MA, Leskinen T, Heinonen IH, Löyttyniemi E, Eskelinen J-J,
Virtanen K, et al. Right ventricular metabolic adaptations to high-intensity
interval and moderate-intensity continuous training in healthy middle-aged
men. Am J Physiol Heart Circ Physiol. 2016;311:H667–75.
26. Heiskanen MA, Sjöros TJ, Heinonen IHA, Löyttyniemi E, Koivumäki M,
Motiani KK, et al. Sprint interval training decreases left-ventricular glucose
uptake compared to moderate-intensity continuous training in subjects
with type 2 diabetes or prediabetes. Sci Rep. 2017;7:10531.
27. Honkala SM, Johansson J, Motiani KK, Eskelinen J-J, Virtanen KA, Löyttyniemi
E, et al. Short-term interval training alters brain glucose metabolism in
subjects with insulin resistance. J Cereb Blood Flow Metab. 2018;38:1828–38.
Heiskanen et al. BMC Sports Science, Medicine and Rehabilitation           (2021) 13:16 Page 18 of 19
28. Motiani KK, Savolainen AM, Eskelinen J-J, Toivanen J, Ishizu T, Yli-Karjanmaa
M, et al. Two weeks of moderate intensity continuous training, but not high
intensity interval training increases insulin-stimulated intestinal glucose
uptake. J Appl Physiol. 2017;122:1188–97.
29. Heiskanen MA, Motiani KK, Mari A, Saunavaara V, Eskelinen JJ, Virtanen KA,
et al. Exercise training decreases pancreatic fat content and improves beta
cell function regardless of baseline glucose tolerance: a randomised
controlled trial. Diabetologia. 2018;61:1817–28.
30. Motiani KK, Savolainen AM, Toivanen J, Eskelinen J, Yli-karjanmaa M,
Virtanen KA, et al. Effects of short-term sprint interval and moderate-
intensity continuous training on liver fat content , lipoprotein profile , and
substrate uptake : a randomized trial. J Appl Physiol. 2019;126:1756–68.
31. Honkala SM, Motiani KK, Eskelinen J-J, Savolainen A, Saunavaara V, Virtanen
KA, et al. Exercise training reduces intrathoracic fat regardless of defective
glucose tolerance. Med Sci Sports Exerc. 2017;49:1313–22.
32. Motiani KK, Collado MC, Eskelinen J-J, Virtanen KA, Löyttyniemi E, Salminen
S, et al. Exercise Training Modulates Gut Microbiota Profile and Improves
Endotoxemia. Med Sci Sports Exerc. 2019; epub ahead of print.
33. Snowling NJ, Hopkins WG. Effects of Different Modes of Exercise Training on
Glucose Control and Risk Factors for Complications in Type 2 Diabetic Patients.
Diabetes Care. 2006;29:2518 LP–2527. https://doi.org/10.2337/dc06-1317.
34. Ismail I, Keating SE, Baker MK, Johnson NA. A systematic review and meta-
analysis of the effect of aerobic vs. resistance exercise training on visceral fat.
Obes Rev. 2012;13:68–91. https://doi.org/10.1111/j.1467-789X.2011.00931.x.
35. Kaprio J, Bollepalli S, Buchwald J, Iso-Markku P, Korhonen T, Kovanen V, et al.
The older Finnish twin cohort - 45 years of follow-up. Twin Res Hum Genet
Off J Int Soc Twin Stud. 2019;22:240–54.
36. Rose RJ, Salvatore JE, Aaltonen S, Barr PB, Bogl LH, Byers HA, et al.
FinnTwin12 cohort: an updated review. Twin Res Hum Genet Off J Int Soc
Twin Stud. 2019;22:302–11.
37. Kaidesoja M, Aaltonen S, Bogl LH, Heikkilä K, Kaartinen S, Kujala UM, et al.
FinnTwin16: a longitudinal study from age 16 of a population-based Finnish
twin cohort. Twin Res Hum Genet Off J Int Soc Twin Stud. 2019;22:530–9.
38. Heinonen S, Saarinen L, Naukkarinen J, Rodríguez A, Frühbeck G,
Hakkarainen A, et al. Adipocyte morphology and implications for metabolic
derangements in acquired obesity. Int J Obes. 2014;38:1423–31.
39. Rudroff T, Kindred JH, Kalliokoski KK. [18F]-FDG Positron Emission
Tomography - an Established Clinical Tool Opening a New Window into
Exercise Physiology. J Appl Physiol. 2015;118:1181–90.
40. Voipio-Pulkki LM, Nuutila P, Knuuti MJ, Ruotsalainen U, Haaparanta M, Teras
M, et al. Heart and skeletal muscle glucose disposal in type 2 diabetic
patients as determined by positron emission tomography. J Nucl Med.
1993;34:2064–7.
41. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for
quantifying insulin secretion and resistance. Am J Phys. 1979;237:E214–23.
42. Hamacher K, Coenen HH, Stocklin G. Efficient stereospecific synthesis of
nocarrier- added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether
supported nucleophilic substitution. J Nucl Med. 1986;27:235–9.
43. Rissanen E, Tuisku J, Rokka J, Paavilainen T, Parkkola R, Rinne JO, et al. In
vivo detection of diffuse inflammation in secondary progressive multiple
sclerosis using PET imaging and the Radioligand 11C-PK11195. J Nucl Med.
2014;55:939–44.
44. Banati RB, Newcombe J, Gunn RN, Cagnin A, Turkheimer F, Heppner F, et al.
The peripheral benzodiazepine binding site in the brain in multiple
sclerosis. Quantitative in vivo imaging of microglia as a measure of disease
activity. Brain. 2000;123:2321–37.
45. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al.
Recommendations for chamber quantification. Eur J Echocardiogr. 2006;7:
79–108.
46. Mor-Avi V, Lang RM, Badano LP, Belohlavek M, Cardim NM, Derumeaux G,
et al. Current and evolving echocardiographic techniques for the
quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement
on methodology and indications: endorsed by the Japanese Society of
Echocardiography. J Am Soc Echocardiogr. 2011;24:277–313.
47. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, et al.
Recommendations for the evaluation of left ventricular diastolic function by
echocardiography. J Am Soc Echocardiogr. 2009;22:107–33.
48. Adams J. Quantitative computed tomography. Eur J Radiol. 2009;71:415–24.
49. Li N, Li XM, Xu L, Sun WJ, Cheng XG, Tian W. Comparison of QCT and DXA:
osteoporosis detection rates in postmenopausal women. Int J Endocrinol.
2013;2013:5–9.
50. Bergström J. Percutaneous needle biopsy of skeletal muscle in physiological
and clinical research. Scand J Clin Lab Invest. 1975;35:609–16.
51. Anwyl-Irvine AL, Massonnié J, Flitton A, Kirkham N, Evershed JK. Gorilla in
our midst: An online behavioral experiment builder. Behav Res Methods.
2019; Epub ahead of print.
52. Chierchia G, Fuhrmann D, Knoll LJ, Pi-Sunyer BP, Sakhardande AL,
Blakemore SJ. The matrix reasoning item bank (MaRs-IB): novel, open-access
abstract reasoning items for adolescents and adults. R Soc Open Sci. 2019;6.
53. Lang PJ, Greenwald MK, Bradley MM, Hamm AO. Looking at pictures:
affective, facial, visceral, and behavioral reactions. Psychophysiology. 1993;
30:261–73.
54. Lang PJ, Bradley MM, Cuthbert BN. International Affective Picture System
(IAPS): affective ratings of pictures and instruction manual. Technical Report
A-6. Gainesville: University of Florida; 2005.
55. Baecke JA, Burema J, Frijters JE. A short questionnaire for the measurement
of habitual physical activity in epidemiological studies. Am J Clin Nutr. 1982;
36:936–42.
56. Hannukainen JC, Borra R, Linderborg K, Kallio H, Kiss J, Lepomäki V, et al.
Liver and pancreatic fat content and metabolism in healthy monozygotic
twins with discordant physical activity. J Hepatol. 2011;54:545–52.
57. Hannukainen JC, Kujala UM, Toikka J, Heinonen OJ, Kapanen J, Vahlberg T,
et al. Cardiac structure and function in monozygotic twin pairs discordant
for physical fitness. J Appl Physiol. 2005;99:535–41.
58. Kaye SM, Pietiläinen KH, Kotronen A, Joutsi-Korhonen L, Kaprio J, Yki-
Järvinen H, et al. Obesity-related derangements of coagulation and
fibrinolysis a study of obesity-discordant monozygotic twin pairs. Obesity.
2012;20:88–94.
59. Booth FW, Roberts CK, Laye MJ. Lack of exercise is a major cause of chronic
diseases. Compr Physiol. 2012;2:1143–211.
60. Sampath Kumar A, Maiya AG, Shastry BA, Vaishali K, Ravishankar N, Hazari A,
et al. Exercise and insulin resistance in type 2 diabetes mellitus: a systematic
review and meta-analysis. Ann Phys Rehabil Med. 2019;62:98–103. https://
doi.org/10.1016/j.rehab.2018.11.001.
61. Rottensteiner M, Leskinen T, Niskanen E, Aaltonen S, Mutikainen S, Wikgren
J, et al. Physical activity, fitness, glucose homeostasis, and brain morphology
in twins. Med Sci Sports Exerc. 2015;47:509–18.
62. Leskinen T, Sipilä S, Alen M, Cheng S, Pietiläinen KH, Usenius J-P, et al.
Leisure-time physical activity and high-risk fat: a longitudinal population-
based twin study. Int J Obes. 2009;33:1211–8. https://doi.org/10.1038/ijo.2
009.170.
63. Kujala UM, Mäkinen V-P, Heinonen I, Soininen P, Kangas AJ, Leskinen TH,
et al. Long-term leisure-time physical activity and serum metabolome.
Circulation. 2013;127:340–8.
64. Leskinen T, Kujala UM. Health-related findings among twin pairs discordant
for leisure-time physical activity for 32 years: the TWINACTIVE study
synopsis. Twin Res Hum Genet Off J Int Soc Twin Stud. 2015;18:266–72.
65. Hannukainen JC, Nuutila P, Borra R, Kaprio J, Kujala UM, Janatuinen T, et al.
Increased physical activity decreases hepatic free fatty acid uptake: a study
in human monozygotic twins. J Physiol. 2007;578(Pt 1):347–58.
66. Waller K, Kaprio J, Lehtovirta M, Silventoinen K, Koskenvuo M, Kujala UM.
Leisure-time physical activity and type 2 diabetes during a 28 year follow-
up in twins. Diabetologia. 2010;53:2531–7.
67. Karvinen S, Waller K, Silvennoinen M, Koch LG, Britton SL, Kaprio J, et al.
Physical activity in adulthood: genes and mortality. Sci Rep. 2015;5:18259.
68. Berntzen BJ, Jukarainen S, Bogl LH, Rissanen A, Kaprio J, Pietiläinen KH.
Eating behaviors in healthy young adult twin pairs discordant for body
mass index. Twin Res Hum Genet Off J Int Soc Twin Stud. 2019;22:220–8.
69. King NA, Caudwell P, Hopkins M, Byrne NM, Colley R, Hills AP, et al.
Metabolic and behavioral compensatory responses to exercise interventions:
barriers to weight loss. Obesity. 2007;15:1373–83.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Heiskanen et al. BMC Sports Science, Medicine and Rehabilitation           (2021) 13:16 Page 19 of 19
